BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6198848)

  • 1. Bullous and pustular rheumatoid vasculitis: treatment by plasma exchange.
    Ortonne JP; Cassuto-Viguier E; Quaranta JF; Lacour JP; Ziegler G
    Acta Derm Venereol; 1983; 63(6):543-6. PubMed ID: 6198848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma exchange and rheumatoid polyarthritis with vasculitis. Apropos of 6 case reports].
    Roux H; Gaborit P; Bonnefoy-Cudraz M; Deslous-Paoli MP; Fouquet B; Nowakovitch G
    Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):105-9. PubMed ID: 6857123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combined therapy with plasmapheresis and immunosuppressants in rheumatoid vasculitis.
    Winkelstein A; Starz TW; Agarwal A
    J Rheumatol; 1984 Apr; 11(2):162-6. PubMed ID: 6726715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of severe or vasculitis associated forms of rheumatoid arthritis by plasma exchanges (author's transl)].
    Prier A; Sobel A; Merlet C; Koeger AC; Fabre M; Crouzet J; Camus JP
    Ann Med Interne (Paris); 1982; 133(3):169-73. PubMed ID: 7103303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic rheumatoid vasculitis: a review.
    Genta MS; Genta RM; Gabay C
    Semin Arthritis Rheum; 2006 Oct; 36(2):88-98. PubMed ID: 17023257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange in rheumatoid vasculitis.
    Scott DG; Bacon PA; Bothamley JE; Allen C; Elson CJ; Wallington TB
    J Rheumatol; 1981; 8(3):433-9. PubMed ID: 7288759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of rheumatoid arthritis by plasma exchange].
    Daudin M; Moirot E; Leroy J; Deshayes P
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):289-92. PubMed ID: 6879096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rheumatoid vasculitis and malignant rheumatoid arthritis].
    Aikawa T; Yoshizawa H
    Nihon Rinsho; 1985 Oct; 43(10):2065-9. PubMed ID: 4094087
    [No Abstract]   [Full Text] [Related]  

  • 9. Apheresis: clinical response to patients unresponsive to conventional therapy.
    Sakamoto H; Takaoka T; Usami M; Emura M; Okabe K; Matsushita M; Smith JW; Malchesky PS; Nose Y
    Trans Am Soc Artif Intern Organs; 1985; 31():704-10. PubMed ID: 3837535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid vasculitis in a patient with seronegative rheumatoid arthritis.
    Ikeda E; Uchigasaki S; Endo M; Shibata M; Suzuki H
    Eur J Dermatol; 1998 Jun; 8(4):268-70. PubMed ID: 9649673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.
    Matsunawa M; Isozaki T; Odai T; Yajima N; Takeuchi HT; Negishi M; Ide H; Adachi M; Kasama T
    Arthritis Rheum; 2006 Nov; 54(11):3408-16. PubMed ID: 17075825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange in two patients with rheumatoid vasculitis.
    Bjelle A; Cedergren B; Wählby L
    Scand J Rheumatol; 1982; 11(1):58-62. PubMed ID: 7063814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in rheumatoid vasculitis.
    Brubaker DB; Winkelstein A
    Vox Sang; 1981; 41(5-6):295-301. PubMed ID: 6976658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical and immunomorphological characteristics of rheumatoid vasculitis].
    Filipowicz-Sosnowska A; Garwolińska G; Wagner T
    Ter Arkh; 1992; 64(11):95-7. PubMed ID: 1293856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
    Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
    Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lethal complications and associated diseases of rheumatoid arthritis--a retrospective clinicopathologic study of 234 autopsy patients].
    Bély M; Apáthy A
    Orv Hetil; 2006 Jun; 147(23):1063-76. PubMed ID: 16856508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of plasma exchange therapy in patients with rheumatoid arthritis and systemic manifestations].
    Achenbach H; Häntzschel H; Würzberger G; Seidel W; Otto W
    Z Gesamte Inn Med; 1986 Mar; 41(6):174-6. PubMed ID: 3716511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential cryoglobulinemic vasculitis with severe peripheral neuropathy and neurogenic muscular atrophy -- inducing remission by cascade filtration].
    Strunk J; Taborski U; Neeck G
    Z Rheumatol; 2002 Dec; 61(6):733-9. PubMed ID: 12491140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchange in severe rheumatoid arthritis complicated by extra-articular manifestations.
    Raymakers RA; Boerbooms AM; Van de Putte LB; De Witte TJ
    Neth J Med; 1984; 27(3):65-8. PubMed ID: 6709111
    [No Abstract]   [Full Text] [Related]  

  • 20. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis.
    Combe B; Didry C; Gutierrez M; Anaya JM; Sany J
    Eur J Med; 1993 Mar; 2(3):153-6. PubMed ID: 8261056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.